Home | Contact Us | FAQ | Search & Site Map | Link to Us
Sign In | Join | Other 45 Sites in Network
Home
Discussion Groups
General
GeneralCardiologyVisionDentistryPharmacyLaboratoryNutritionAlternative
Diseases and Disorders
AIDSAlzheimer'sArthritisAsthmaCancerBreast CancerDiabetesEpilepsyGlaucomaHepatitisHerpesLupusProstate BPHProstate CancerProstatitisSinusitisTinnitus

Medical Forum / Diseases and Disorders / Breast Cancer / August 2004

Tip: Looking for answers? Try searching our database.

Any results yet of Herceptin (Trastuzumab) adjuvant Breast Cancer trials?

Thread view: 
Enable EMail Alerts  Start New Thread
Thread rating: 
BJ - 26 Aug 2004 01:23 GMT
There are some ongoing trials that intend to evaluate the use of
Herceptin (Trastuzumab) in the adjuvant setting for women having had
breast cancer and who test positive for HER-2. The researchers are
looking into whether it would be a good idea to give wimen Herceptin
(Trastuzumab) after initial chemo and radiation to decrease the risk
for the cancer to return.
 
As I have a long-term girlfriend who have got breast cancer I would be
most interested in any interimistic results of these trials, if any
are at hand. In my country there is only one trial (the HERA trial)
that is possible for her to participate in. In that trial there is a
chance of one in three that she will not get any Herceptin.

I would be very interested in knowing if it would be worth the cost
and hard work to get her on Herceptin off-protocol if she gets into
the arm which has no Herceptin.

My girlfriend had a 18 millimeter tumour in the right breast and 7 out
of 7 lymph nodes were contaminated, although on microscopic level. The
tumour was tested HER-2 positive by FISH and is ER/Pr++++. The general
outlook of the tumour was rated Elston grade III. The treatment so far
has been 6 x FEC (Epirubicin was 75 mg/m2, chemococtail given every
three weeks).

Due to her HER-2 positivity, she is sheduled for 3 or 4 more chemo
treatments but now with Epirubicin and Taxotere (75 mg/m2 of both).
Then radiation and thereafter anastrozole (an aromatose inhibitor). No
signs of distant metastases yet.

As far as I have been able to conclude from extensive research on the
Internet, the above would make her a high-risk candidate for
metastases. I have a gut-feeling that there must be something that can
be done in addition to the above to decrease the risk that she will
eventually develop metastases. Herceptin is the only drug that I come
to think about, but then one must have a fair amount of trust that it
actually will do some good, hence my keen interest in the interemistic
results of these trials.

Thanks in advance

BJ.

To reply by e-mail, please remove the leading X from my e-mailadress
Xforestcat@hotmail.com.
ABdikjse - 26 Aug 2004 04:12 GMT
Yes, unfortunately, one item on Herceptin is in:

ABSTRACT: Incidence of cerebral metastases in patients treated with trastuzumab
for metastatic breast cancer
[08/11/2004; British Journal of Cancer] index

Trastuzumab is an effective treatment for patients with metastatic breast
cancer (MBC) that overexpresses HER-2. A high incidence of brain metastases
(BM) has been noted in patients receiving trastuzumab. A retrospective chart
review was conducted of 100 patients commencing trastuzumab for metastatic
breast cancer from July 1999 to December 2002, at the Christie Hospital. Seven
patients were excluded; five patients developed central nervous system
metastases prior to starting trastuzumab, and inadequate data were available
for two. Out of the remaining 93 patients, 23 (25%) have developed BM to date.
In all, 46 patients have died, and of these 18 (39%) have been diagnosed with
BM prior to death. Of the 23 patients developing BM, 18 (78%) were hormone
receptor negative and 18 (78%) had visceral disease. Univariate analysis showed
a significant association between the development of cerebral disease and both
hormone receptor status and the presence of visceral disease. In conclusion, a
high proportion of patients with MBC treated with trastuzumab develop
symptomatic cerebral metastases. HER-2-positive breast cancer may have a
predilection for the brain, or trastuzumab therapy may change the disease
pattern by prolonging survival. New strategies to address this problem require
investigation in this group of patients.

Lady8
Eva - 26 Aug 2004 12:23 GMT
Does this apply to people who are being treated with Herceptin as regular
chemo too?  I'm supposed to start it in a few weeks and this post has scared
the hell out of me.
Eva
-------------
> Yes, unfortunately, one item on Herceptin is in:
>
[quoted text clipped - 22 lines]
>
> Lady8
Tim Jackson - 27 Aug 2004 22:31 GMT
> Does this apply to people who are being treated with Herceptin as regular
> chemo too?  I'm supposed to start it in a few weeks and this post has scared
> the hell out of me.
> Eva

The abstract does NOT show that Herceptin -causes- brain mets.  It shows a
correlation between the two, which could for example be simply due to
Herceptin being less effective across the blood-brain barrier.  In other
words it doesn't cause them, but it fails to cure them.

There is no evidence here to scare you, or to support withdrawing from
Herceptin treatment.

Tim Jackson
allan grossman - 28 Aug 2004 18:52 GMT
On Fri, 27 Aug 2004 22:31:10 +0100, "Tim Jackson"

>The abstract does NOT show that Herceptin -causes- brain mets.  It shows a
>correlation between the two, which could for example be simply due to
[quoted text clipped - 3 lines]
>There is no evidence here to scare you, or to support withdrawing from
>Herceptin treatment.

Almost *no* cancer treatment crosses the blood-brain barrier - the
only one I can think of is Temodar - which isn't really indicated for
breast cancer anyway.

Herceptin is a large-molecule compound - in tests the concentration of
Herceptin in CSF is about 300x the concentration in someone's blood.
It's not that Herceptin causes brain mets, it's that (as Tim said) it
doesn't cross the blood-brain barrier - so if you have a response
it'll generally be everywhere *except* your brain.

There have been some tests of Herceptin injected directly into the
spine - but I think those tests are ongoing.

allan

Signature

we don't see things as they are, we see them as we are.
-- Anais Nin

allan grossman - 29 Aug 2004 23:30 GMT
>Herceptin is a large-molecule compound - in tests the concentration of
>Herceptin in CSF is about 300x the concentration in someone's blood.

I got this backwards.  In tests, the concentration of Herceptin in
blood was ~300x the concentration in CSF.  I figure y'all knew what I
meant  ;-)

hugs to all -

allan

Signature

we don't see things as they are, we see them as we are.
-- Anais Nin

Eva - 30 Aug 2004 05:33 GMT
> >Herceptin is a large-molecule compound - in tests the concentration of
> >Herceptin in CSF is about 300x the concentration in someone's blood.
[quoted text clipped - 6 lines]
>
> allan
----------
That's okay, I didn't know what you meant and I still don't!  So I'm good.
Eva
allan grossman - 30 Aug 2004 15:22 GMT
> That's okay, I didn't know what you meant and I still don't!  So I'm good.
> Eva

;-)

Herceptin doesn't cross the blood-brain barrier easily.  There have
been a few tests run where they found the concentration of Herceptin
in someone's blood is 300 times higher than the concentracion of
Herceptin in the same person's spinal fluid.

What this means is that Herceptin does a pretty good job of killing
the nasties everywhere *except* in someone's nervous system.  IM
frequently less than HO this means that the increased incidence of
brain metastasis in folks who have received Herceptin is because the
drug can't get to that part of your body.

As I mentioned in another post, Herceptin is a large-molecule drug.
Your nervous system has a pretty efficient filter to keep stuff that
shouldn't get to your brain away from that area, and unfortunately
Herceptin doesn't make it through that barrier very well either.

So - it's my opinion that the folks who develop brain metastasis after
Herceptin are doing so because they're living longer than they
normally would have, not because Herceptin increases the likelihood of
brain mets.

There have been some test cases where they injected Herceptin directly
into the spine to fight brain mets but this is still being tested and
isn't approved for general use.

Being Her2 positive isn't an automatic death sentence and I don't
think there's any clinical evidence to support the idea that Her2
positive tumors metastasize quicker than other tumors.  It is
generally accepted that Her2+ tumors are a bit more aggressive than
others, but any oncologist will tell you that *any* breast tumor left
unchecked will metastasize at some point - and that some do earlier
than others.  There's simply no way to tell at what point a tumor will
start shedding cells into one's bloodstream.

So - although it's easy for me to sit here and tell someone else not
to worry, being Her2+ is *not* an automatic death sentence and does
*not* mean that the tumors shed cells faster than others or anything
awful like that.  There's simply no clinical evidence to support that
hypothesis.  It *does* mean that on average Her2+ tumors grow faster
than others, and that may (or may not) mean they metastasize quicker
but there's no clinical evidence to support that.  Each tumor is
different.

My wife Deborah is Her2+ and was diagnosed with lung metastasis even
before she had her mastectomy.  Herceptin has saved her life twice -
and more than five years out from a Stage IV diagnosis she's healthy
and reasonably happy.  As a matter of fact, if things continue to
progress the way they have been for the past sis months we'll be off
chemo again next month.

No one's telling you there's nothing to cling to, Eva - as a matter of
fact I'm telling you exactly the opposite.  It's not over until your
oncologist says it's time to give up - and that may be a long way off
- or never.

hugs -

allan
Eva - 31 Aug 2004 00:06 GMT
Thank you so much for this kind and thoughtful post.
Eva

> > That's okay, I didn't know what you meant and I still don't!  So I'm good.
> > Eva
[quoted text clipped - 59 lines]
>
> allan
Guess Who - 28 Aug 2004 13:36 GMT
This  study was not a random study, it is well known that patients who are
HER/2 positive are high risk for mets.
If you did a chart review of women of 100 women with non invasive breast
cancer (DCIS) you would find almost 100% these women didn't have  bone mets,
therefore could you conclude NOT having chemo prevents bone mets if you used
the parameters of her/2 study.
Eva - 28 Aug 2004 20:38 GMT
> This  study was not a random study, it is well known that patients who are
> HER/2 positive are high risk for mets.
> If you did a chart review of women of 100 women with non invasive breast
> cancer (DCIS) you would find almost 100% these women didn't have  bone mets,
> therefore could you conclude NOT having chemo prevents bone mets if you used
> the parameters of her/2 study.
------------
I think you're being unnecessarily sarcastic with me here, Guess Who.  What
was posted seemed quite alarming.
"In conclusion, a high proportion of patients with MBC treated with
trastuzumab develop
symptomatic cerebral metastases."

It then went on to say:

"HER-2-positive breast cancer may have a predilection for the brain, or
trastuzumab therapy may change the disease pattern by prolonging survival."

I hope it prolongs my survival.  I have a lot of stuff left to do in this
world.  However, brain metastases are particularly horrible to me, since
they mean living one's last months in a state of dementia.

Eva
allan grossman - 29 Aug 2004 14:18 GMT
>I hope it prolongs my survival.  I have a lot of stuff left to do in this
>world.  However, brain metastases are particularly horrible to me, since
>they mean living one's last months in a state of dementia.

This is not necessarily true.

I've known a couple of women who died of brain mets - neither was in a
particularly demented state when she passed on.  I enjoyed
corresponding with one of them until about 48 hours before she passed
away - then a seizure, coma and she passed peacefully.  The other lost
her sight about a week before she died - but again, no dementia.

Knowledge is power.

allan

Signature

we don't see things as they are, we see them as we are.
-- Anais Nin

Eva - 30 Aug 2004 08:36 GMT
Basically what I am hearing in this newsgroup is that I am foolish to have
any hope of survival, because I am HER2 positive.  It is not a matter of
whether this this will kill me, it is only a matter of when.  It's going to
metastasize if it hasn't already, and all of these "weapons" that are making
me so sick are ultimately useless.  Well, I never was a real upbeat person
to begin with so I can't say I'm in the least surprised, but my God, isn't
there like a *10%* chance or *something* to cling to?
allan grossman - 30 Aug 2004 10:53 GMT
>Basically what I am hearing in this newsgroup is that I am foolish to have
>any hope of survival, because I am HER2 positive.  It is not a matter of
[quoted text clipped - 3 lines]
>to begin with so I can't say I'm in the least surprised, but my God, isn't
>there like a *10%* chance or *something* to cling to?

I haven't heard anybody say that.  It's true that HER2+ cells tend to
be more aggressive but no one here said it was time to just hang it
up.  I haven't heard anyone say things were hopeless.

My wife has been on and off Herceptin for almost five years.  There's
no doubt the drug is keeping her alive, but she's most certainly alive
- and doing quite well, thankyouverymuch  ;-)

allan

Signature

we don't see things as they are, we see them as we are.
-- Anais Nin

Tim Jackson - 30 Aug 2004 19:15 GMT
> Basically what I am hearing in this newsgroup is that I am foolish to have
> any hope of survival, because I am HER2 positive.  It is not a matter of
[quoted text clipped - 3 lines]
> to begin with so I can't say I'm in the least surprised, but my God, isn't
> there like a *10%* chance or *something* to cling to?

No-one said that it was hopeless and you have a perfectly good chance of
recovery.

I don't know what your history is, but if you have not been diagnosed as
stage IV (metastatic or secondary) cancer then the fact that you are HER2
positive does not really much affect your survival chances.  HER2+ cancers
tend to be more aggressive, but as you are aware, they are also treatable
with Herceptin, which somewhat cancels out the increased risk.  The best
indicators of metastasis risk are tumour size and number of lymph nodes
involved.

The survey you were referring to was a survey of patients who's cancer had
already metastasised, so that was a whole different picture.

You can look up your metastasis risk on the Imaginis website
http://www.imaginis.com/breasthealth/statistics.asp
Find "Staging and Survival Rates" near the bottom of the page, if you don't
know your stage follow the link to the staging page where it is explained.

What is true is that once it has metastasised, THEN AND ONLY THEN, is it
most likely a permanent condition that you would die with, and you would be
unlikely to live more than ten years ten years beyond diagnosis of that
condition.  But right now that isn't you.

Tim Jackson
Eva - 31 Aug 2004 00:32 GMT
> No-one said that it was hopeless and you have a perfectly good chance of
> recovery.
[quoted text clipped - 14 lines]
> Find "Staging and Survival Rates" near the bottom of the page, if you don't
> know your stage follow the link to the staging page where it is explained.
-----------
Thank you, that's a very clear and helpful site.

I'm sorry if I got kind of hysterical there when I posted.  I was having a
really bad night.  Then I read Catharine's biography and freaked out
altogether.

Eva
allan grossman - 31 Aug 2004 00:45 GMT
>I'm sorry if I got kind of hysterical there when I posted.  I was having a
>really bad night.  Then I read Catharine's biography and freaked out
>altogether.

There's no need to apologize, Eva.  There are more than a few people
here who can tell you of me being scared witless on more than one
occasion.

Today you can lean on us - six months from now I may need to lean on
you.  That's the way it works.

I met Catharine in person twice - and took her passing pretty hard.
There were a couple of times that she held me up when I didn't know
how to stand on my own.  She went through life - and through her
passing - with style and grace.  I was very lucky to know her - we all
were.

hugs -

allan

Signature

we don't see things as they are, we see them as we are.
-- Anais Nin

Tim Jackson - 31 Aug 2004 02:11 GMT
> I'm sorry if I got kind of hysterical there when I posted.  I was having a
> really bad night.  Then I read Catharine's biography and freaked out
> altogether.

Yes I still miss her too.

I never met her in the flesh, but I got to know her well through a lengthy
correspondence that maybe I'll publish one day.  She was so strong
physically and mentally, but she got scared inside too just like the rest of
us.

What she was that was different was she was always aware of what was
happening to her, emotionally and physically, she could stand outside her
body and see the funny side of her fear or pain or embarrassment, and wasn't
afraid to talk about it.  Like a war reporter or a test pilot.  And boy,
could she write.

Tim
Guess Who - 30 Aug 2004 22:37 GMT
Signature

 Well, I never was a real upbeat person

> to begin with so I can't say I'm in the least surprised, but my God, isn't
> there like a *10%* chance or *something* to cling to?

And there are less toxic 2nd generation of herceptin like drugs in clinical
trials. look very promising.PS we are all going to die breast cancer or not.
Eva - 31 Aug 2004 00:05 GMT
---------
No sh.t.  I work in a nursing home, I've seen plenty of death and I even
know there are worse things than cancer.

Eva
Kaye301 - 26 Aug 2004 04:56 GMT
Hi BJ, I had adjuvent Herceptin off-protocol.  It was given to me because I was
at very high risk for recurrence.  I only had it for a year though and am very
concerned about recurrence--because of my extremely high risk status.
There are now trials to give it to women in the neoadjuvent setting.  One gal I
correspond with got it that way along and is doing exceptionally well.
I do wish your girlfriend all the best!   She is very fortunate to have such a
caring  and concerned partner.   Take care...
 
Sign In
Join
My Latest Posts
My Monitored Threads
My Blog
My Photo Gallery
My Profile
My Homepage

Start New Thread
Enable EMail Alerts
Rate this Thread



©2009 Advenet LLC   Privacy Policy - Terms of Use
This website includes both content owned or controlled by Advenet as well as content owned or controlled by third parties.